In a prospective multicenter study across emergency departments of a tertiary and a regional hospital, the UCD® device was evaluated for managing difficult urethral catheterization (DUC) in men. Approved by the TGA and enabling non-specialists to use the Seldinger technique, UCD® was effective in 65% of 20 DUC cases. It reduced the need for expensive emergency urology interventions, saving costs of around A$2500 per patient on inter-hospital transfers (A$800 to A$1300) and call-backs (A$540). The device proved particularly valuable in regional hospitals, minimizing delays and costs associated with patient transfers for urology services.

In a prospective multicenter study across emergency departments of a tertiary and a regional hospital, the UCD® device was evaluated for managing difficult urethral catheterization (DUC) in men. Approved by the TGA and enabling non-specialists to use the Seldinger technique, UCD® was effective in 65% of 20 DUC cases. It reduced the need for expensive emergency urology interventions, saving costs of around A$2500 per patient on inter-hospital transfers (A$800 to A$1300) and call-backs (A$540). The device proved particularly valuable in regional hospitals, minimizing delays and costs associated with patient transfers for urology services.

Men who have undergone phalloplasty may experience challenges with urethral catheterization due to urethral tortuosity related to the surgery. This randomized controlled trial shows that using the UCD® catheter results in a 60% success rate for catheterization, which is twice as high as the success rate achieved with standard Foley catheters, and does so without any complications related to the procedure.

In a prospective single-center study across emergency and operating room departments of a regional hospital, the UCD® device was assessed over a 12 month period for its effectiveness in managing failed urethral catheterization in male patients. Approved by Swissmedic and enabling non-specialists to use the Seldinger technique, the UCD® catheter was effective in 81% of 21 DUC cases. It reduced the need for urology referral, thereby saving both time and healthcare costs. All staff were highly satisfied with the new device and would use it again as the next step to solve difficult urethral catheterization.

This study examined the efficacy of the UCD® (Urethrotech Ltd), a urethral catheterization device equipped with an integrated guidewire, in male patients where standard Foley catheter insertion was unsuccessful at the end of intricate urethroplasty surgeries. In 94% of the instances (15 out of 16), the UCD® catheter was effectively inserted on the first attempt in less than 5 minutes. The sole remaining case achieved success on a second try without any complications. Demonstrating effectiveness, time-efficiency, and safety for patients undergoing complex urethral surgery, the UCD® eliminated the necessity for cystoscopy-assisted catheter placement, which carries an increased risk of harming new anastomotic repairs through irrigation and instrumentation.

This cohort study recorded the incidence of catheterization-associated urethral injury (CAUI) in 74 consecutive men undergoing cardiac surgery using a standard Foley catheter, followed by 100 similar men being catheterized with the UCD® catheter, featuring an integrated guidewire. The use of the UCD® catheter was successful in all men on the first attempt, without any adverse events, whereas 7 adverse events (9.5%) occurred in the Foley catheter group with post-operative bleeding and pain in 5 patients (6.8%), and 2 patients (2.7%) required placement of a suprapubic catheter at the end of the cardiac procedure despite the need for high-dose post-operative anticoagulation. The findings suggest that the UCD® catheter offers a safer option for urethral catheterization in high-risk patients, such as those undergoing cardiac surgery who will be administered heparin, by reducing the high risk of complications associated with traditional Foley catheterization.